FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/Obesity

JACC Advances 2026 Open access

Read full text
Authors: Dzuy Do, Karthik Murugiah, Mitsuaki Sawano, Brianna M. Goodwin Cartwright, Patricia J. Rodriguez, Samuel Gratzl, Lesley H. Curtis, Ania Jastreboff, Yuan Lu, Nicholas L. Stucky
DOI: 10.1016/j.jacadv.2025.102575
Cited by: 1
References: 4

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Heart Failure Treatment and Management

Publication details

Journal / source
JACC Advances
Publisher
Elsevier BV
Volume
5
Issue
2
Pages
102575–102575
Publication date
22 January 2026
Language
EN